GlaxoSmithKline CFO Interviewed on Q2 Results
LONDON, July 24, 2013
LONDON, July 24, 2013 /PRNewswire/ --
Simon Dingemans, CFO, outlines the UK pharma group's Q2 performance, positive
R&D pipeline news, as well as outlook and guidance for the rest of the year.
Dingemans also gives an update on his financial strategy plan, saying, "you
could see in the second quarter the benefits of the restructuring programmes
and some of the financial efficiencies we've identified really contributing to
drive that leverage through the P&L and accelerate earnings per share of 4%
faster than the sales growth of two per cent."
The video interviews and transcripts are available now on
MerchantCantos produces in-depth interviews, documentaries and webcasts with
senior company executives. If you would like to contact us, please email
firstname.lastname@example.org or phone +44-(0)207-936-1352.
Press spacebar to pause and continue. Press esc to stop.